Publication
[S3 guidelines on exocrine pancreatic cancer 2024 : Consequences for the surgical practice].
Thomas Hank, Martin Loos, Christoph Michalski
Chirurgie (Heidelberg, Germany)Sep 16, 2026PMID 42747481doi:10.1007/s00104-026-02561-7 English AbstractJournal ArticleReviewpubmedProvenance
- Source
- PubMed
- Retrieved
- Sep 19, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260919-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
The updated S3 guidelines on exocrine pancreatic cancer (version 3.1, 2024) bring several practice-relevant adaptations for the diagnostics and treatment. The preoperative staging is extended and treatment decisions are influenced increasingly more by the tumor biology. Neoadjuvant treatment is the…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Pancreatic Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available
No curated evidence item cites this publication.